Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion type Assertion NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_head.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion description "[Imatinib is effective in patients with increased mast cells and eosinophils associated with FIP1L1/PDGFRA+ (e.g., myeloid neoplasm with eosinophilia and rearrangement of PDGFRA) or rare patients with SM associated with KIT mutations outside of exon 17.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_provenance.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion evidence source_evidence_literature NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_provenance.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion SIO_000772 21641642 NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_provenance.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion wasDerivedFrom befree-20150227 NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_provenance.
- NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_assertion wasGeneratedBy ECO_0000203 NP613919.RAx3-jgMCMipnN9ixnLWBC7Aq2efAnxm4UHtpZj50JSV8130_provenance.